只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 交易日 / 申报日 | 公司 | 申报人 | 类型 | 股数 | 每股价格 | 派生金额 | 持有后股数 | 原始申报 |
|---|---|---|---|---|---|---|---|---|
| 2026-07-28 2026-07-30 | RLAY Relay Therapeutics, Inc. | Catinazzo Thomas Officer · Chief Financial Officer | 卖出（S） | 1,459 | US$18.61 | US$27,151.99 | 158,285 | SEC |
| 2026-07-06 2026-07-08 | RLAY Relay Therapeutics, Inc. | Catinazzo Thomas Officer · Chief Financial Officer | 卖出（S） | 17,717 | US$18.69 | US$331,130.73 | 159,744 | SEC |
| 2026-06-22 2026-06-24 | RLAY Relay Therapeutics, Inc. | Catinazzo Thomas Officer · Chief Financial Officer | 卖出（S） | 56,323 | US$16.97 | US$955,801.31 | 177,461 | SEC |
| 2026-06-22 2026-06-24 | RLAY Relay Therapeutics, Inc. | Catinazzo Thomas Officer · Chief Financial Officer | 卖出（S） | 61,563 | US$16.97 | US$104.47万 | 177,461 | SEC |
| 2026-06-22 2026-06-24 | RLAY Relay Therapeutics, Inc. | Catinazzo Thomas Officer · Chief Financial Officer | 卖出（S） | 51,560 | US$16.97 | US$874,973.20 | 177,461 | SEC |
| 2026-06-22 2026-06-24 | RLAY Relay Therapeutics, Inc. | Catinazzo Thomas Officer · Chief Financial Officer | 卖出（S） | 17,717 | US$17.01 | US$301,366.17 | 177,461 | SEC |
| 2026-05-22 2026-06-12 | PRKS United Parks & Resorts Inc. | Finazzo Christopher L. Officer · Chief Commercial Officer | 卖出（S） | 8,000 | US$36.76 | US$294,080.00 | 130,285 | SEC |
| 2026-05-14 2026-05-14 | RLAY Relay Therapeutics, Inc. | Catinazzo Thomas Officer · Chief Financial Officer | 卖出（S） | 17,717 | US$12.86 | US$227,840.62 | 195,178 | SEC |
| 2026-04-28 2026-04-30 | RLAY Relay Therapeutics, Inc. | Catinazzo Thomas Officer · Chief Financial Officer | 卖出（S） | 972 | US$14.79 | US$14,375.88 | 212,895 | SEC |
| 2026-04-24 2026-04-24 | WULF TERAWULF INC. | Khan Nazar M. Director,Officer · Chief Technology Officer | 卖出（S） | 452,152 | US$0.00 | US$0.00 | 738,626 | SEC |
| 2026-04-09 2026-04-09 | RLAY Relay Therapeutics, Inc. | Catinazzo Thomas Officer · Chief Financial Officer | 卖出（S） | 1,800 | US$15.00 | US$27,000.00 | 213,867 | SEC |
| 2026-04-07 2026-04-09 | RLAY Relay Therapeutics, Inc. | Catinazzo Thomas Officer · Chief Financial Officer | 卖出（S） | 17,717 | US$13.01 | US$230,498.17 | 213,867 | SEC |
| 2026-04-02 2026-04-03 | FDP FRESH DEL MONTE PRODUCE INC | Tenazas Marissa R Officer · SVP, CHRO | 卖出（S） | 1,046 | US$40.40 | US$42,258.40 | 8,049.9 | SEC |
| 2025-11-12 2026-04-03 | AKA A.K.A. BRANDS HOLDING CORP. | Eskenazi Ilene Director | 卖出（S） | 12,201 | US$12.89 | US$157,270.89 | 5,852 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| NAZ | 6,344 | 0 | 8,492.8157 | 74.70% | B, Q |
| RNAZ | 1,258.2014 | 3 | 4,301.5888 | 29.25% | Q, N |